Postscripts from the Post-Coronary Artery Bypass Graft trial: the sustained benefit of more aggressive cholesterol lowering and the enigma of low-dose anticoagulation
- PMID: 10889122
- DOI: 10.1161/01.cir.102.2.144
Postscripts from the Post-Coronary Artery Bypass Graft trial: the sustained benefit of more aggressive cholesterol lowering and the enigma of low-dose anticoagulation
Comment in
-
Niacin after coronary bypass grafting and for coronary disease prevention.Circulation. 2001 Jul 10;104(2):E7. doi: 10.1161/01.cir.104.2.e7. Circulation. 2001. PMID: 11447097 No abstract available.
Comment on
-
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.Circulation. 2000 Jul 11;102(2):157-65. doi: 10.1161/01.cir.102.2.157. Circulation. 2000. PMID: 10889125 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
